Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment deci
Head to Head Analysis: Cancer Genetics (NASDAQ:CGIX) and Castle Biosciences (NASDAQ:CSTL)
01:28am, Tuesday, 14'th Jul 2020
Cancer Genetics (NASDAQ:CGIX) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of the
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of an indep
What Type Of Shareholders Own The Most Number of Castle Biosciences, Inc. (NASDAQ:CSTL) Shares?
05:39pm, Monday, 06'th Jul 2020
A look at the shareholders of Castle Biosciences, Inc. (NASDAQ:CSTL) can tell us which group is most powerful...
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
09:00pm, Thursday, 02'nd Jul 2020
Castle announced the underwriters have exercised in full their option to purchase an additional 300,000 shares.
Guardant Health (GH) Receives a Buy from Canaccord Genuity - Markets
09:31am, Thursday, 02'nd Jul 2020
In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
12:00am, Thursday, 02'nd Jul 2020
Castle announced the underwriters have exercised in full their option to purchase an additional 300,000 shares.
'My husband died from a cancer that is preventable'
05:00am, Wednesday, 01'st Jul 2020
Cliona Murphy lost her husband Brendan to melanoma three years ago. Here, she talks about the difference new treatments made to extending his life, as well as the need for fundraising to continue rese
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
02:38pm, Friday, 26'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc. (NASDAQ:CSTL) and determine whether it is a good investment right now. We at Insider Monkey l
Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
01:33am, Thursday, 25'th Jun 2020
Castle Biosciences announced today the pricing of its underwritten public offering.
Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
12:00am, Thursday, 25'th Jun 2020
Castle Biosciences announced today the pricing of its underwritten public offering.
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
08:34pm, Monday, 22'nd Jun 2020Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
08:33pm, Monday, 22'nd Jun 2020
Castle Biosciences has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC).
Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
12:00am, Monday, 22'nd Jun 2020
Castle Biosciences has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC).
